Linden Advisors’s Revelation Biosciences, Inc. Warrant REVBW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Hold |
338,110
| – | – | ﹤0.01% | 375 |
|
|
2025
Q1 | $3.7K | Hold |
338,110
| – | – | ﹤0.01% | 302 |
|
|
2024
Q4 | $2.51K | Hold |
338,110
| – | – | ﹤0.01% | 260 |
|
|
2024
Q3 | $5.07K | Hold |
338,110
| – | – | ﹤0.01% | 264 |
|
|
2024
Q2 | $5.8K | Hold |
338,110
| – | – | ﹤0.01% | 277 |
|
|
2024
Q1 | $9.09K | Sell |
338,110
-377,642
| -53% | -$10.2K | ﹤0.01% | 289 |
|
|
2023
Q4 | $8.86K | Hold |
715,752
| – | – | ﹤0.01% | 293 |
|
|
2023
Q3 | $10.6K | Hold |
715,752
| – | – | ﹤0.01% | 334 |
|
|
2023
Q2 | $12.8K | Hold |
715,752
| – | – | ﹤0.01% | 347 |
|
|
2023
Q1 | $12.8K | Hold |
715,752
| – | – | ﹤0.01% | 415 |
|
|
2022
Q4 | $9.25K | Hold |
715,752
| – | – | ﹤0.01% | 497 |
|
|
2022
Q3 | $36K | Buy |
715,752
+378,000
| +112% | +$19K | ﹤0.01% | 543 |
|
|
2022
Q2 | $26K | Sell |
337,752
-378,000
| -53% | -$29.1K | ﹤0.01% | 641 |
|
|
2022
Q1 | $86K | Buy |
715,752
+56,926
| +9% | +$6.84K | ﹤0.01% | 599 |
|
|
2021
Q4 | $452K | Hold |
658,826
| – | – | ﹤0.01% | 559 |
|
|
2021
Q3 | $412K | Hold |
658,826
| – | – | ﹤0.01% | 489 |
|
|
2021
Q2 | $419K | Hold |
658,826
| – | – | ﹤0.01% | 571 |
|
|
2021
Q1 | $343K | Sell |
658,826
-20,174
| -3% | -$10.5K | ﹤0.01% | 609 |
|
|
2020
Q4 | $591K | Buy |
+679,000
| New | +$591K | ﹤0.01% | 405 |
|